Decoding neurodegeneration one cell at a time.
Research
The Journal of clinical investigation
March 16, 2026
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Trial
Phase 1
Recruiting
March 15, 2026
Terazosin And Metabolic Energetics in Parkinson's Disease
Trial
Phase 2
Not yet recruiting
March 15, 2026
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Trial
N/A
Completed
March 15, 2026
Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease
Trial
Phase 2
Completed
March 15, 2026
UB-312 in Patients With Synucleinopathies
Trial
Phase 1
Completed
March 15, 2026
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
Trial
N/A
Recruiting
March 15, 2026
Paraquat induces neuroinflammation through glycolytic reprogramming in microglia: evidence from network toxicology analysis and in vitro experiments.
Research
Chemico-biological interactions
March 14, 2026
New insights into synaptic vesicle dysfunction in Parkinson's disease
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
March 13, 2026
Genotype-associated outcomes after deep brain stimulation in Parkinson's disease: a systematic review, meta-analysis and epigenetic implications.
Research
Neurologia i neurochirurgia polska
March 13, 2026
Effects of daily walking exercise on constipation in patients with Parkinson's disease.
Research
BMJ open sport & exercise medicine
March 13, 2026
Putamen dopamine synthesis, vesicular storage, and metabolism in Parkinson disease.
Research
medRxiv : the preprint server for health sciences
March 13, 2026
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
Trial
Phase 2
Not yet recruiting
March 12, 2026
Montelukast in Parkinson Disease
Trial
Phase 2
Recruiting
March 12, 2026
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease
Trial
Phase 1
Completed
March 12, 2026
Exercise to Improve Sleep in Parkinson's Disease
Trial
N/A
Recruiting
March 12, 2026
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Trial
Phase 2
Completed
March 12, 2026
Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease
Trial
Phase 4
Terminated
March 12, 2026